Gentex (NASDAQ: GNTX) insider transactions
In the twelve months to 10 November 2026, executives and directors of Gentex reported 13 open-market sales of 114,459 shares ($2.8m) and 0 open-market purchases, by 9 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 21 May 2026 | Kennedy John C | Director | Grant or award | +5,626 | — | 5,626 | Form 4 |
| 21 May 2026 | Walker Brian C | Director | Grant or award | +5,626 | — | 29,831 | Form 4 |
| 21 May 2026 | Deur Garth | Director | Grant or award | +5,626 | — | 20,045 | Form 4 |
| 21 May 2026 | Schaum Richard O | Director | Grant or award | +5,626 | — | 87,069 | Form 4 |
| 21 May 2026 | Brown Leslie L | Director | Grant or award | +5,626 | — | 41,988 | Form 4 |
| 21 May 2026 | Starkoff Kathleen | Director | Grant or award | +5,626 | — | 36,770 | Form 4 |
| 21 May 2026 | Zang Ling | Director | Grant or award | +5,626 | — | 35,599 | Form 4 |
| 21 May 2026 | Pink Billy | Director | Grant or award | +5,626 | — | 15,329 | Form 4 |
| 15 May 2026 | Walker Brian C | Director | Open-market sale | −5,939 | $22.98 | 24,205 | Form 4 |
| 15 May 2026 | Anderson Joseph B JR | Director | Open-market sale | −5,939 | $22.98 | 0 | Form 4 |
| 5 May 2026 | Brown Leslie L | Director | Option exercise | +7,000 | $15.74 | 40,144 | Form 4 |
| 5 May 2026 | Brown Leslie L | Director | Option exercise | +7,000 | $18.70 | 47,144 | Form 4 |
| 5 May 2026 | Brown Leslie L | Director | Open-market sale | −10,782 | $22.85 | 36,362 | Form 4 |
| 30 April 2026 | Schaum Richard O | Director | Option exercise | +7,000 | $15.74 | 86,258 | Form 4 |
| 30 April 2026 | Schaum Richard O | Director | Open-market sale | −4,815 | $23.31 | 81,443 | Form 4 |
| 19 February 2026 | Nash Kevin C | Chief Financial Officer | Grant or award | +13,880 | — | 73,310 | Form 4 |
| 19 February 2026 | Downing Steven R | President and CEO | Grant or award | +43,492 | — | 255,162 | Form 4 |
| 19 February 2026 | Ryan Scott P | General Counsel | Grant or award | +11,000 | — | 55,279 | Form 4 |
| 19 February 2026 | Chiodo Matthew | Vice President of Sales | Grant or award | +12,047 | — | 47,148 | Form 4 |
| 19 February 2026 | Boehm Neil | Chief Technology Officer | Grant or award | +14,953 | — | 73,904 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Gentex page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.